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Automatic Bio-Sample Bacteria Detection System 
An automatic electromechanical device dramatically 
reduces the time required for bio-sample analysis 
in the detection of bacteria. Bio-samples, such as 
urine specimens, can be analyzed in IS minutes, and the 
instrument processes a sample a minute. Since urinary 
tract infections are indications of kidney or bladder 
disease or diabetes, and since the occurrence of such
With the device just developed, the time and skill 
required for such analyses are minimized, and, al-
though the unit has only been built in prototype, it 
is conceivable that it could be made portable for non-
laboratory use. 
Basic research behind the system design concerned 
means of detecting microbiological life on other plan-
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infections in the United States is second only to that of 
respiratory ailments, urinalysis is one of the most im-
portant and frequently conducted procedures in the 
clinical laboratory. 
Present urinalysis techniques involve incubating 
the specimen with a nutrient for one or two days, and 
counting the visible number of bacterial colonies. 
This number provides an accurate index of the number 
of viable cells capable of dividing. However, consider-
able time is required to complete the analysis, and the 
process can onl y
 he performed in the laboratory by 
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ets, using two chemicals —luciferase and luciferin - 
found in the common firefly. These chemicals produce 
a bioluminescent reaction when in contact with aden-
osine triphosphate (ATP), which is found in all living 
organisms. In urine samples, the concentration of 
bacterial ATP is directly proportional to the number 
of bacteria present in the sample. 
In operation, the vials containing the urine samples 
are placed in openings in the periphery of the revolving 
table inside the light-tight housing. As the table turns, 
a series of spouts located at specific points around the 
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vials to remove ATP from nonbacterial sources and 
release bacterial ATP. The amount of reagent dis-
pensed by each spout is controlled by a pump system 
located outside the housing. At the final test point, a 
photomultiplier tube senses the light from the bio-
luminescent reaction in the urine when the luciferase-
luciferin mixture is added. The output signal from this 
photomultiplier is directly proportional to the bac-
terial ATP concentration, which in turn is propor-
tional to the number of bacteria present in the sample. 
When the reaction measurement is completed, the vials 
are ejected from the table. 
The instrument has potential application to other 
physiological fluids, such as blood or spinal fluid, in 
tests where bacterial count is of immediate importance. 
It can also be used to detect and count bacteria in 
any fluid source containing living organisms, including 
water supplies. 
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Patent status: 
This invention is owned by NASA, and a patent 
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licences for its commercial use will be granted by 
NASA. Inquiries concerning license rights should 
be made to: 
Patent Counsel 
Mail Code 204 
Goddard Space Flight Center 
Greenbelt, Maryland 20771 
Source: Dr. Grace ,
 Lee Picciolo, Burton N. Kelbaugh,

Emmett W. Chappelle, and Maurice Colburn

Goddard Space Flight Center

(G SC- 1 1169)
n 
[1 
Brief 71-10055 Category 04
